Skip to main content
SpringerLink
Log in

Nierenverträglichkeit von Cefsulodin: Kommentar zu der tierexperimentellen Studie von G. Burmann et al.

  • Published:
Infection Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Tune, B. M. Effect of organic acid transport inhibitors on renal cortical uptake and proximal tubular toxicity of cephaloridine. J. Pharmacol. Exp. Ther. 181 (1972) 250–256.

    PubMed  CAS  Google Scholar 

  2. Tune, B. M., Fernholt, M. Relationship between cephaloridine and p-aminohippurate transport in the kidney. Amer. J. Physiol. 225 (1973) 1114–1117.

    PubMed  CAS  Google Scholar 

  3. Atkinson, R. M., Currie, J. P., Davis, B. et al. Acute toxicity of cephaloridine, an antibiotic derived from cephalosporin C. Toxicol. Appl. Pharmacol. 8 (1966) 398–406.

    Article  CAS  PubMed  Google Scholar 

  4. Tune, B. M. Relationship between the transport and toxicity of cephalosporins in the kidney. J. Infect. Dis. 132 (1975) 189–194.

    Article  CAS  PubMed  Google Scholar 

  5. Wachsmuth, E. D. Quantification of nephrotoxicity in rabbits by automated morphometry of alkaline phosphatase stained kidney sections. Histochemistry 71 (1981) 235–248.

    Article  CAS  PubMed  Google Scholar 

  6. Sack, K., Freiesleben, H. Experimentelle Untersuchungen zur potentiellen Nephrotoxizität von Tobramycin, Gentamicin und Sisomicin. Infection 3 (1975) 40–48.

    Article  Google Scholar 

  7. Sack, K., Freiesleben, H., Züllich, B. et al. Nebenwirkungen von Aminoglykosiden: Nephrotoxizität. Infection 4 (1976) 231–238.

    Article  CAS  PubMed  Google Scholar 

  8. Ahrens, T., Vischer, W., Imhof, P. et al. Human pharmacology of CGP 7174/E (SCE-129) and initial results of clinical trials in Europe. Drugs Exptl. Clin. Res. 5 (1979) 61–70.

    CAS  Google Scholar 

  9. Graininger, W., Spitzy, K. H., Pichler, H. et al. Cefsulodin (CGP 7174/E) in the treatment ofPseudomonas infections in intensive-care patients. In:Nelson, J. D., Grassi, C. (eds.): Current Chemotherapy and Infectious Disease, Proc. 11th Int. Congr. Chemother., Boston 1979 (Amer. Soc. Microbiol., Washington 1980), p. 200.

    Google Scholar 

  10. Daikos, G. K., Giamarellou, H., Dispiraki, K. et al. Clinical, bacteriological, and pharmacokinetic study of cefsulodin in seriousPseudomonas aeruginosa infections. In:Nelson, J. D., Grassi, C. (eds.): Current Chemotherapy and Infectious Disease, Proc. 11th Int. Congr. Chemother., Boston 1979 (Amer. Soc. Microbiol., Washington 1980), p. 202.

    Google Scholar 

  11. Guibert, J., Kitzis, M. D., Acar, J. F. Clinical evaluation of cefsulodin (CGP 7174/E) in urinary tract infections caused byPseudomonas aeruginosa. In:Nelson, J. D., Grassi, C. (eds.): Current Chemotherapy and Infectious Disease, Proc. 11th Int. Congr. Chemother., Boston 1979 (Amer. Soc. Microbiol., Washington 1980), p. 199.

    Google Scholar 

  12. Mashimo, K. Clinical experience with cefsulodin in pseudomonal urinary tract infections. In:Sabath, L. D. (ed.): Pseudomonas aeruginosa. Int. Symp., Boston 1979 (Huber, Bern/Stuttgart/Wien 1980), p. 240.

    Google Scholar 

  13. Meyer, H. CGP 7174/E, a new anti-Pseudomonas antibiotic in cystic fibrosis. In:Sabath, L. D. (ed.): Pseudomonas aeruginosa. Int. Symp., Boston 1979 (Huber, Bern/Stuttgart/Wien 1980), p. 241.

    Google Scholar 

  14. Guibert, J.: Evaluation clinique de la cefsulodine. 2e Congr. Méditerranéen de Chimiothér., Nizza 1980, Abstr. 275.

  15. Naber, K., Rugendorff, E., Kees, F. et al.: Cefsulodin: Pharmacokinetics in volunteers and therapeutic efficacy in treatment of complicated urinary tract infection caused byPseudomonas aeruginosa. 2e Congr. Méditerranéen de Chimiothér., Nizza 1980, Abstr. 276.

  16. Rosenkranz, A.: Clinical and bacteriological results of treatment with cefsulodin (CGP 7174) in infants withPseudomonas aeruginosa infections. 2e Congr. Méditerranéen de Chimiothér., Nizza 1980, Abstr. 277.

  17. Giamarellou, H., Koumaditis, A., Dispiraki, K. et al.: Pharmacokinetic studies with cefsulodin. 2e Congr. Méditerranéen de Chimiothér., Nizza 1980, Abstr. 466.

  18. Ahrens, T. Die Behandlung von Pseudomonasinfektionen mit Cefsulodin — Vorläufige Ergebnisse einer klinischen Prüfung in Europa. Krankenhausarzt 54 (1981) 558–566.

    Google Scholar 

  19. Rugendorff, E. W., Röhrborn, C. Klinische Erfahrungen in der Behandlung von kompliziertenPseudomonas-Harnwegsinfektionen mit Cefsulodin. Krankenhausarzt 54 (1981) 567–570.

    Google Scholar 

  20. Vossmann, H., Zellner, P. R., Metzger, E. Die Indikation von Cefsulodin bei schwer Brandverletzten. Krankenhausarzt 54 (1981) 571–573.

    Google Scholar 

  21. Helm, E. B., Shah, P. M., Stille, W. Klinische Erfahrungen mit Cefsulodin. Krankenhausarzt 54 (1981) 574–577.

    Google Scholar 

  22. Ahrens, T.: Treatment ofPseudomonas infections with cefsulodin: results of a multicentre clinical trial in Europe. 12th Int. Congr. Chemother., Florenz, 19–24 Juli 1981.

  23. Ruf, K. B. III. Monaspor® (Cefsulodin): Clinical and pharmacological profile of a unique antibiotic, highly effective againstPseudomonas aeruginosa. Pharmamanual 1: A comprehensive guide to the therapeutic use of cefsulodin. Karger, Basel/München/Paris/London/New York/Sydney 1980.

    Google Scholar 

  24. Wachsmuth, E. D., Thomann, P. Testing for renal tolerability of cefsulodin in rats and rabbits. J. Appl. Toxicol. 1 (1981) No. 4, XXII.

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nierenverträglichkeit von Cefsulodin: Kommentar zu der tierexperimentellen Studie von G. Burmann et al.. Infection 9, 237–238 (1981). https://doi.org/10.1007/BF01640723

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01640723

Search

Navigation